Learning study to improve vision support for macular degeneration
Part of Eyes & vision clinical trials.
This study focuses on adults with macular degeneration and aims to improve how well you can use your remaining vision. It uses learning and brain stimulation, so it may help you notice and use your vision more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with macular degeneration (AMD if age 60+, or JMD if age 18+).
- Your eyesight in your better eye is reduced but still within a specific range (between 6/9 and 6/96).
- Your near vision (with best correction) is at least 4.0M at 40 cm in your better eye.
- Your central vision has been affected, and your vision has been stable for the past 3 months.
- You do not have dementia, and you can read either English (Waterloo site) or Chinese characters (Hong Kong site).
- You cannot have recent eye procedures or certain brain-stimulation risks during the study period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the eye’s “central vision” area and connected brain learning/adjustment work in people with advanced macular degeneration. You may be asked to do vision testing using special eye-scanning equipment and follow study procedures that could help researchers better understand the disease.
This study tests a new way to measure vision, called MLSDT, in people with normal sight or vision loss from Stargardt disease or geographic atrophy (a type of advanced age-related macular degeneration). Results will help doctors better understand how well patients can see.
This study tests a new treatment to improve vision in people with advanced age-related macular degeneration (AMD). If you have significant vision loss from AMD, this might help you see better.
This study tests whether a safe, noninvasive brain stimulation technique (called tDCS) can help people with vision loss from retinitis pigmentosa, rod-cone dystrophy, or advanced glaucoma move around more easily and safely. Participants will do walking and orientation tasks while receiving the stimulation.
This study tests a device that delivers mild electrical stimulation to the eye to see if it can improve vision in people with early or intermediate dry age-related macular degeneration. It aims to find a safe treatment that may slow down the disease or improve visual function.
This trial tests whether combining a short vision learning program with non-invasive electrical stimulation to the brain can improve vision in people with open-angle or normal-tension glaucoma. It may help by training the visual system while stimulating brain pathways to support vision.
Hear when a new Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.